| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology and Biophysics, University of Calgary, Calgary, Alberta, Canada
2 Department of Pharmacology, Kaohsiung Medical University, Kaohsiung, Taiwan
* To whom correspondence should be addressed. E-mail: dwelsh{at}ucalgary.ca.
This study examined whether, and by what signaling and ionic mechanisms, pyrimidine nucleotides constrict rat cerebral arteries. Cannulated cerebral arteries stripped of endothelium and pressurized to 15 mmHg constricted in a dose-dependent manner to UTP. This constriction was partly dependent on the depolarization of smooth muscle cells and the activation of voltage-operated Ca2+ channels. The depolarization and constriction induced by UTP were unaffected by Bisindolylmaleimide I, a PKC inhibitor that abolished phorbol ester (phorbol 12-myristate 13-acetate)-induced constriction in cerebral arteries. In contrast, the Rho-kinase inhibitor Y-27632 attenuated the ability of UTP to both constrict and depolarize cerebral arteries. Using patch clamp electrophysiology, a voltage-dependent delayed rectifying K+ (KDR) current was isolated and shown to consist of a slowly inactivating 4-aminopyridine (4-AP) sensitive, and insensitive component. The 4-AP-sensitive KDR current was potently suppressed by UTP through a mechanism that was not dependent on protein kinase C (PKC). This reflects observations which demonstrated that: 1) a PKC activator (Phorbol-12-myristate-13-acetate) had no effect on KDR; and 2) PKC inhibitors (Calphostin C or Bisindolylmaleimide I) could not prevent the suppression of KDR by UTP. The Rho-kinase inhibitor, Y-27632, abolished the ability of UTP to inhibit the KDR current as did inhibition of RhoA with C3 exoenzyme. Cumulatively, these observations indicate that Rho-kinase signaling plays an important role in eliciting the cerebral constriction induced by pyrimidine nucleotides. Moreover, they demonstrate for the first time that Rho-kinase partly mediates this constriction by altering ion channels which control membrane potential and Ca2+ influx through voltage-operated Ca2+ channels.
This article has been cited by other articles:
|
|
 |
|
  P. D. Smith, S. E. Brett, K. D. Luykenaar, S. L. Sandow, S. P. Marrelli, E. J. Vigmond, and D. G. Welsh KIR channels function as electrical amplifiers in rat vascular smooth muscle J. Physiol., February 15, 2008; 586(4): 1147 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Telezhkin, T. Goecks, A. D. Bonev, G. Osol, and N. I. Gokina Decreased function of voltage-gated potassium channels contributes to augmented myogenic tone of uterine arteries in late pregnancy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H272 - H284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Corteling, S. E. Brett, H. Yin, X.-L. Zheng, M. P. Walsh, and D. G. Welsh The functional consequence of RhoA knockdown by RNA interference in rat cerebral arteries Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H440 - H447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Luykenaar and D. G. Welsh Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2654 - H2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Jantzi, S. E. Brett, W. F. Jackson, R. Corteling, E. J. Vigmond, and D. G. Welsh Inward rectifying potassium channels facilitate cell-to-cell communication in hamster retractor muscle feed arteries Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1319 - H1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chrissobolis and C. G. Sobey Recent Evidence for an Involvement of Rho-Kinase in Cerebral Vascular Disease Stroke, August 1, 2006; 37(8): 2174 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Gokina, K. M. Park, K. McElroy-Yaggy, and G. Osol Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity J Appl Physiol, May 1, 2005; 98(5): 1940 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Reading, S. Earley, B. J. Waldron, D. G. Welsh, and J. E. Brayden TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2055 - H2061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagaoka, K. A. Fagan, S. A. Gebb, K. G. Morris, T. Suzuki, H. Shimokawa, I. F. McMurtry, and M. Oka Inhaled Rho Kinase Inhibitors Are Potent and Selective Vasodilators in Rat Pulmonary Hypertension Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 494 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Plane, R. Johnson, P. Kerr, W. Wiehler, K. Thorneloe, K. Ishii, T. Chen, and W. Cole Heteromultimeric Kv1 Channels Contribute to Myogenic Control of Arterial Diameter Circ. Res., February 4, 2005; 96(2): 216 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Shabir, L Borisova, S. Wray, and T Burdyga Rho-kinase inhibition and electromechanical coupling in rat and guinea-pig ureter smooth muscle: Ca2+-dependent and -independent mechanisms J. Physiol., November 1, 2004; 560(3): 839 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Sylvester The tone of pulmonary smooth muscle: ROK and Rho music? Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L624 - L630. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
